Stephen Machatha

Insider Reports History

Entity
Individual
Location
131 Hartwell Avenue, Suite 320, Lexington, MA
Signature
/s/ Stephen Machatha
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Machatha:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aldeyra Therapeutics, Inc. Chief Development Officer Common Stock 237K $1.12M $4.74 Aug 12, 2024 Direct
Aldeyra Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 405K Mar 9, 2024 Direct

Insider Reports Filed by Stephen Machatha

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALDX Aldeyra Therapeutics, Inc. Aug 12, 2024 1 -$76K 4 Aug 14, 2024 Chief Development Officer
ALDX Aldeyra Therapeutics, Inc. Mar 12, 2024 1 -$36.5K 4/A Apr 17, 2024 Chief Development Officer
ALDX Aldeyra Therapeutics, Inc. Mar 9, 2024 3 -$98.6K 4 Mar 12, 2024 Chief Development Officer
ALDX Aldeyra Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 2, 2023 Chief Development Officer
ALDX Aldeyra Therapeutics, Inc. Jul 15, 2022 2 $0 4 Jul 19, 2022 Chief Development Officer
ALDX Aldeyra Therapeutics, Inc. Mar 30, 2022 2 $0 4 Apr 1, 2022 Chief Development Officer